Verisk (VRSK) Q3 2026 Earnings Call Transcript

Verisk reported Q3 revenue of $809 million, up 7.4% on an organic constant-currency basis, with adjusted EBITDA up 7.5% to $459 million and adjusted EPS up 14% to $1.96. Management reaffirmed 2026 revenue guidance of $3.19 billion–$3.24 billion and adjusted EPS guidance of $7.45–$7.75, while noting softer property markets, below-average weather activity and longer sales cycles may weigh on Q4 transactional revenue. AI-related products and data offerings are gaining client interest, and the company repurchased 10.5 million shares for $1.9 billion in the first nine months of 2026; free cash flow fell 40.5% to $200 million.

Analysis

Verisk’s more durable upside is not a near-term “AI revenue” step-change: management says much AI access is currently bundled into existing contracts, with value captured through renewals and pricing. That favors gradual monetization over the next 12–24 months, while customer governance and validation requirements constrain the pace. The strategic test is whether Verisk can turn proprietary, industry-wide data into repeatable workflow value; if so, AI may strengthen its data moat even as generic models commoditize software features. Broader E&S and image datasets can reinforce a contributor flywheel, though adoption and incremental economics still need verification.

Near term, do not extrapolate the quarter’s transactional upside: management identified sources that may not recur, while softer property activity and low weather volumes remain headwinds. Contractor/adjuster distress is a contained but relevant collection risk, not evidence of broad customer impairment. The $171 billion modeled catastrophe estimate supports long-run demand for risk analytics, but is not a forecast of this year’s event-driven claims volumes. Margin gains also may be partly reinvested in product and go-to-market rather than fully reaching earnings. Watch cash conversion separately from adjusted EPS, which benefited from buybacks; higher interest expense and leverage reduce flexibility if acquisition spending or collections disappoint. AccuLynx remains an uncertain regulatory catalyst.

Contrarian read: AI enthusiasm may overstate immediate sales conversion, but understate the pricing power of trusted data once insurers validate use cases. The thesis weakens if subscription momentum or price realization fades, sales cycles do not convert into broader licenses, collections deteriorate, or guidance is cut.

Key Decisions for Investors

• VRSK: avoid chasing the print; consider initiating or adding on post-earnings weakness if subscription growth and full-year guidance remain intact. This is a 6–18 month data-monetization thesis, not a near-term AI acceleration trade.
• Over the next 1–3 months, track renewal pricing, conversion of AI pilots into paid or expanded deployments, and whether bundled access shifts toward separately licensed products. Treat management’s productivity claim as an opportunity, not yet as a forecast of incremental margin.
• Keep exposure sized for softer property transactions and contractor/adjuster collection risk. Reassess if customer receivables or cash conversion weaken, or if subscription growth and pricing trends materially decelerate; stronger adoption by large carriers and stable collections would support the thesis.
• Do not assign value to AccuLynx closing until FTC review and customary conditions are resolved. Verify deal timing, financing implications, and any updated capital-return plans before treating it as a catalyst.